Close
Nordic 9Nordic 9

Nonacus (investor - Corporate Investor)

United Kingdom
See something wrong or missing? Let us know
Offices:Birmingham
Average round investment:1.8M USD
Average number per year:1.0
Distribution: 2023 (1)
Portfolio companies: United Kingdom CanSense
Mostly invests in: United Kingdom United Kingdom (1) Health services (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Nonacus

Name Criteria
United Kingdom Catapult Ventures
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States First In Ventures
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Arkitekt Ventures
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany KHAN Technology Transfer Fund
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Cumulus Oncology
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Israel Nadav Rosenberg
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Sweden Enexis AB
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom Jude Gomila
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom Deepbridge Capital
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
France Oskare Capital
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Top